These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28284204)

  • 41. Low 25-OH vitamin D is associated with benign prostatic hyperplasia.
    Haghsheno MA; Mellström D; Behre CJ; Damber JE; Johansson H; Karlsson M; Lorentzon M; Peeker R; Barret-Connor E; Waern E; Sundh V; Ohlsson C; Hammarsten J
    J Urol; 2013 Aug; 190(2):608-14. PubMed ID: 23399651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of a nanocomposite containing Orbignya speciosa lipophilic extract on Benign Prostatic Hyperplasia.
    de Souza PA; Palumbo A; Alves LM; de Souza VP; Cabral LM; Fernandes PD; Takiya CM; Menezes FS; Nasciutti LE
    J Ethnopharmacol; 2011 Apr; 135(1):135-46. PubMed ID: 21396436
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia.
    Stephan C; Lein M; Jung K; Schnorr D; Loening SA
    Cancer; 1997 Jan; 79(1):104-9. PubMed ID: 8988733
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Response of prostate volume, prostate-specific antigen, and testosterone to flutamide in men with benign prostatic hyperplasia.
    Stone NN; Clejan SJ
    J Androl; 1991; 12(6):376-80. PubMed ID: 1722793
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recovery of serum prostate specific antigen value after interruption of antiandrogen therapy with allylestrenol for benign prostatic hyperplasia.
    Noguchi K; Suzuki K; Teranishi J; Kondo K; Kishida T; Saito K; Uemura H; Kubota Y
    Hinyokika Kiyo; 2006 Jul; 52(7):527-30. PubMed ID: 16910584
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of phytotherapy on utility scores for 5 benign prostatic hyperplasia/lower urinary tract symptoms health states.
    Dedhia RC; Calhoun E; McVary KT
    J Urol; 2008 Jan; 179(1):220-5. PubMed ID: 18001791
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety and efficacy of a novel Prunus domestica extract (Sitoprin, CR002) on testosterone-induced benign prostatic hyperplasia (BPH) in male Wistar rats.
    Swaroop A; Bagchi M; Kumar P; Preuss HG; Bagchi D
    Toxicol Mech Methods; 2015; 25(9):653-64. PubMed ID: 26337762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Status of phytotherapeutic drugs in treatment of benign prostatic hyperplasia].
    Dreikorn K; Schönhöfer PS
    Urologe A; 1995 Mar; 34(2):119-29. PubMed ID: 7538709
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiproliferative activity of aqueous leaf extract of Annona muricata L. on the prostate, BPH-1 cells, and some target genes.
    Asare GA; Afriyie D; Ngala RA; Abutiate H; Doku D; Mahmood SA; Rahman H
    Integr Cancer Ther; 2015 Jan; 14(1):65-74. PubMed ID: 25411208
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phytotherapeutic agents in the management of symptomatic benign prostatic hyperplasia.
    Fitzpatrick JM; Lynch TH
    Urol Clin North Am; 1995 May; 22(2):407-12. PubMed ID: 7539185
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Specific antigen prostatic changes during treatment with finasteride or dutasteride for benign prostatic hyperplasia].
    Arena F
    Minerva Urol Nefrol; 2013 Sep; 65(3):211-6. PubMed ID: 23872632
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels.
    Ramos CG; Carvahal GF; Mager DE; Haberer B; Catalona WJ
    J Urol; 1999 Nov; 162(5):1587-90. PubMed ID: 10524873
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intermediate-conductance Ca2+-activated K+ channel, KCa3.1, as a novel therapeutic target for benign prostatic hyperplasia.
    Ohya S; Niwa S; Kojima Y; Sasaki S; Sakuragi M; Kohri K; Imaizumi Y
    J Pharmacol Exp Ther; 2011 Aug; 338(2):528-36. PubMed ID: 21602424
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Rebound of prostate specific antigen after discontinuation of antiandrogen therapy for benign prostatic hyperplasia].
    Noguchi K; Uemura H; Takeda M; Sekiguchi Y; Ogawa K; Hosaka M
    Hinyokika Kiyo; 2000 Sep; 46(9):605-7. PubMed ID: 11107528
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Croton membranaceus Improves Some Biomarkers of Cardiovascular Disease and Diabetes in Genetic Animal Models.
    Asare GA; Adjei S; Afriyie D; Appiah-Danquah AB; Asia J; Asiedu B; Santa S; Doku D
    J Clin Diagn Res; 2015 Dec; 9(12):OF01-5. PubMed ID: 26816938
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Traditional medicines and alternative practice in the management of prostate diseases in southern Ghana.
    Kyei MY; Klufio GO; Ayamba A; Mohammed S
    Ghana Med J; 2017 Sep; 51(3):128-137. PubMed ID: 29622824
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effectivity of phytotherapeutic agent prostavit for the treatment of benign prostate hyperplasia].
    Matjosaitis A; Radavicius A
    Medicina (Kaunas); 2002; 38 Suppl 1():59-62. PubMed ID: 12556637
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Using the planetary health framework to assess phytotherapeutic agents in the treatment of benign prostatic hyperplasia.
    Faure N
    Prog Urol; 2023 May; 33(6):285-286. PubMed ID: 36870915
    [No Abstract]   [Full Text] [Related]  

  • 59. Zn, Ca and Na levels in the prostatic secretion of patients with prostatic adenoma.
    Romics I; Bach D
    Int Urol Nephrol; 1991; 23(1):45-9. PubMed ID: 1718918
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-atherogenic and anti-ischemic potentials of Croton membranaceus observed during sub-chronic toxicity studies.
    Afriyie DK; Asare GA; Bugyei K; Asiedu-Gyekye I; Gyan BA; Adjei S; Addo P; Sittie A; Nyarko AK
    Pharmacognosy Res; 2013 Jan; 5(1):10-6. PubMed ID: 23598919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.